Although plasma IL-35 level did not correlate with absolute T cell counts, in vitro exogenous IL-35 stimulation suppressed T cell activity in PBC patients, which presented as inhibiting of IL-17/IL-22 production by CD4+ T cells and dampening cytotoxicity of CD8+ T cells. The gene discussed is CD8A; the disease is primary biliary cholangitis.